Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy

Cancer Care Ontario
Cancer Care Ontario
Publication date:
16 January 2019


Guideline Objective

The objective of this guideline is to provide clinical practice recommendations for the use of biodegradable spacers for prostate cancer treatment.

Patient Population

Patients undergoing radiation treatment for localized prostate cancer

Intended Guideline Users

Radiation oncologists and genitourinary oncologists involved in the management of prostate cancer.

Research Questions

Does the use of biodegradable hydrogel spacers during RT for prostate cancer decrease rectal (and other) toxicities and maintain QOL following treatment